Cargando…
Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine
KRAS is one of the most highly mutated oncoproteins, which is overexpressed in various human cancers and implicated in poor survival. The G-quadruplex formed in KRAS oncogene promoter (KRAS-G4) is a transcriptional modulator and amenable to small molecule targeting. However, no available KRAS-G4-lig...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556435/ https://www.ncbi.nlm.nih.gov/pubmed/36224201 http://dx.doi.org/10.1038/s41467-022-33761-4 |
_version_ | 1784807077948948480 |
---|---|
author | Wang, Kai-Bo Liu, Yushuang Li, Jinzhu Xiao, Chengmei Wang, Yingying Gu, Wei Li, Yipu Xia, Yuan-Zheng Yan, Tingdong Yang, Ming-Hua Kong, Ling-Yi |
author_facet | Wang, Kai-Bo Liu, Yushuang Li, Jinzhu Xiao, Chengmei Wang, Yingying Gu, Wei Li, Yipu Xia, Yuan-Zheng Yan, Tingdong Yang, Ming-Hua Kong, Ling-Yi |
author_sort | Wang, Kai-Bo |
collection | PubMed |
description | KRAS is one of the most highly mutated oncoproteins, which is overexpressed in various human cancers and implicated in poor survival. The G-quadruplex formed in KRAS oncogene promoter (KRAS-G4) is a transcriptional modulator and amenable to small molecule targeting. However, no available KRAS-G4-ligand complex structure has yet been determined, which seriously hinders the structure-based rational design of KRAS-G4 targeting drugs. In this study, we report the NMR solution structures of a bulge-containing KRAS-G4 bound to berberine and coptisine, respectively. The determined complex structure shows a 2:1 binding stoichiometry with each compound recruiting the adjacent flacking adenine residue to form a “quasi-triad plane” that stacks over the two external G-tetrads. The binding involves both π-stacking and electrostatic interactions. Moreover, berberine and coptisine significantly lowered the KRAS mRNA levels in cancer cells. Our study thus provides molecular details of ligand interactions with KRAS-G4 and is beneficial for the design of specific KRAS-G4-interactive drugs. |
format | Online Article Text |
id | pubmed-9556435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-95564352022-10-14 Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine Wang, Kai-Bo Liu, Yushuang Li, Jinzhu Xiao, Chengmei Wang, Yingying Gu, Wei Li, Yipu Xia, Yuan-Zheng Yan, Tingdong Yang, Ming-Hua Kong, Ling-Yi Nat Commun Article KRAS is one of the most highly mutated oncoproteins, which is overexpressed in various human cancers and implicated in poor survival. The G-quadruplex formed in KRAS oncogene promoter (KRAS-G4) is a transcriptional modulator and amenable to small molecule targeting. However, no available KRAS-G4-ligand complex structure has yet been determined, which seriously hinders the structure-based rational design of KRAS-G4 targeting drugs. In this study, we report the NMR solution structures of a bulge-containing KRAS-G4 bound to berberine and coptisine, respectively. The determined complex structure shows a 2:1 binding stoichiometry with each compound recruiting the adjacent flacking adenine residue to form a “quasi-triad plane” that stacks over the two external G-tetrads. The binding involves both π-stacking and electrostatic interactions. Moreover, berberine and coptisine significantly lowered the KRAS mRNA levels in cancer cells. Our study thus provides molecular details of ligand interactions with KRAS-G4 and is beneficial for the design of specific KRAS-G4-interactive drugs. Nature Publishing Group UK 2022-10-12 /pmc/articles/PMC9556435/ /pubmed/36224201 http://dx.doi.org/10.1038/s41467-022-33761-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wang, Kai-Bo Liu, Yushuang Li, Jinzhu Xiao, Chengmei Wang, Yingying Gu, Wei Li, Yipu Xia, Yuan-Zheng Yan, Tingdong Yang, Ming-Hua Kong, Ling-Yi Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine |
title | Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine |
title_full | Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine |
title_fullStr | Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine |
title_full_unstemmed | Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine |
title_short | Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine |
title_sort | structural insight into the bulge-containing kras oncogene promoter g-quadruplex bound to berberine and coptisine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556435/ https://www.ncbi.nlm.nih.gov/pubmed/36224201 http://dx.doi.org/10.1038/s41467-022-33761-4 |
work_keys_str_mv | AT wangkaibo structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT liuyushuang structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT lijinzhu structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT xiaochengmei structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT wangyingying structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT guwei structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT liyipu structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT xiayuanzheng structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT yantingdong structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT yangminghua structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine AT konglingyi structuralinsightintothebulgecontainingkrasoncogenepromotergquadruplexboundtoberberineandcoptisine |